Clozapine use in Parkinson's disease : A retrospective analysis of a large multicentered clinical experience
Identifieur interne : 003042 ( PascalFrancis/Corpus ); précédent : 003041; suivant : 003043Clozapine use in Parkinson's disease : A retrospective analysis of a large multicentered clinical experience
Auteurs : R. M. Trosch ; J. H. Friedman ; M. C. Lannon ; R. Pahwa ; D. Smith ; L. C. Seeberger ; C. F. O'Brien ; P. A. Lewitt ; W. C. KollerSource :
- Movement disorders [ 0885-3185 ] ; 1998.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 98-0262009 INIST |
---|---|
ET : | Clozapine use in Parkinson's disease : A retrospective analysis of a large multicentered clinical experience |
AU : | TROSCH (R. M.); FRIEDMAN (J. H.); LANNON (M. C.); PAHWA (R.); SMITH (D.); SEEBERGER (L. C.); O'BRIEN (C. F.); LEWITT (P. A.); KOLLER (W. C.) |
AF : | Department of Neurology, Wayne State University School of Medicine/Detroit, Michigan/Etats-Unis (1 aut., 8 aut.); Division of Neurology, Roger Williams Medical Center/Providence, Rhode Island/Etats-Unis (2 aut., 3 aut.); Department of Neurology, University of Kansas Medical Center/Kansas City, Kansas/Etats-Unis (4 aut., 5 aut., 9 aut.); The Colorado Neurological Institute/Denver, Colorado/Etats-Unis (6 aut., 7 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1998; Vol. 13; No. 3; Pp. 377-382; Bibl. 37 ref. |
LA : | Anglais |
CC : | 002B02B03 |
FD : | Parkinson maladie; Trouble psychiatrique; Clozapine; Neuroleptique; Chimiothérapie; Traitement; Homme; Etude multicentrique |
FG : | Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative |
ED : | Parkinson disease; Mental disorder; Clozapine; Neuroleptic; Chemotherapy; Treatment; Human; Multicenter study |
EG : | Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease |
GD : | Aufbereiten |
SD : | Parkinson enfermedad; Trastorno psiquiátrico; Clozapina; Neuroléptico; Quimioterapia; Tratamiento; Hombre; Estudio multicéntrico |
LO : | INIST-20953.354000075575650010 |
ID : | 98-0262009 |
Links to Exploration step
Pascal:98-0262009Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Clozapine use in Parkinson's disease : A retrospective analysis of a large multicentered clinical experience</title>
<author><name sortKey="Trosch, R M" sort="Trosch, R M" uniqKey="Trosch R" first="R. M." last="Trosch">R. M. Trosch</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Wayne State University School of Medicine</s1>
<s2>Detroit, Michigan</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Friedman, J H" sort="Friedman, J H" uniqKey="Friedman J" first="J. H." last="Friedman">J. H. Friedman</name>
<affiliation><inist:fA14 i1="02"><s1>Division of Neurology, Roger Williams Medical Center</s1>
<s2>Providence, Rhode Island</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lannon, M C" sort="Lannon, M C" uniqKey="Lannon M" first="M. C." last="Lannon">M. C. Lannon</name>
<affiliation><inist:fA14 i1="02"><s1>Division of Neurology, Roger Williams Medical Center</s1>
<s2>Providence, Rhode Island</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Pahwa, R" sort="Pahwa, R" uniqKey="Pahwa R" first="R." last="Pahwa">R. Pahwa</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, University of Kansas Medical Center</s1>
<s2>Kansas City, Kansas</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Smith, D" sort="Smith, D" uniqKey="Smith D" first="D." last="Smith">D. Smith</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, University of Kansas Medical Center</s1>
<s2>Kansas City, Kansas</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Seeberger, L C" sort="Seeberger, L C" uniqKey="Seeberger L" first="L. C." last="Seeberger">L. C. Seeberger</name>
<affiliation><inist:fA14 i1="04"><s1>The Colorado Neurological Institute</s1>
<s2>Denver, Colorado</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="O Brien, C F" sort="O Brien, C F" uniqKey="O Brien C" first="C. F." last="O'Brien">C. F. O'Brien</name>
<affiliation><inist:fA14 i1="04"><s1>The Colorado Neurological Institute</s1>
<s2>Denver, Colorado</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lewitt, P A" sort="Lewitt, P A" uniqKey="Lewitt P" first="P. A." last="Lewitt">P. A. Lewitt</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Wayne State University School of Medicine</s1>
<s2>Detroit, Michigan</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Koller, W C" sort="Koller, W C" uniqKey="Koller W" first="W. C." last="Koller">W. C. Koller</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, University of Kansas Medical Center</s1>
<s2>Kansas City, Kansas</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">98-0262009</idno>
<date when="1998">1998</date>
<idno type="stanalyst">PASCAL 98-0262009 INIST</idno>
<idno type="RBID">Pascal:98-0262009</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003042</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Clozapine use in Parkinson's disease : A retrospective analysis of a large multicentered clinical experience</title>
<author><name sortKey="Trosch, R M" sort="Trosch, R M" uniqKey="Trosch R" first="R. M." last="Trosch">R. M. Trosch</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Wayne State University School of Medicine</s1>
<s2>Detroit, Michigan</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Friedman, J H" sort="Friedman, J H" uniqKey="Friedman J" first="J. H." last="Friedman">J. H. Friedman</name>
<affiliation><inist:fA14 i1="02"><s1>Division of Neurology, Roger Williams Medical Center</s1>
<s2>Providence, Rhode Island</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lannon, M C" sort="Lannon, M C" uniqKey="Lannon M" first="M. C." last="Lannon">M. C. Lannon</name>
<affiliation><inist:fA14 i1="02"><s1>Division of Neurology, Roger Williams Medical Center</s1>
<s2>Providence, Rhode Island</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Pahwa, R" sort="Pahwa, R" uniqKey="Pahwa R" first="R." last="Pahwa">R. Pahwa</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, University of Kansas Medical Center</s1>
<s2>Kansas City, Kansas</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Smith, D" sort="Smith, D" uniqKey="Smith D" first="D." last="Smith">D. Smith</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, University of Kansas Medical Center</s1>
<s2>Kansas City, Kansas</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Seeberger, L C" sort="Seeberger, L C" uniqKey="Seeberger L" first="L. C." last="Seeberger">L. C. Seeberger</name>
<affiliation><inist:fA14 i1="04"><s1>The Colorado Neurological Institute</s1>
<s2>Denver, Colorado</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="O Brien, C F" sort="O Brien, C F" uniqKey="O Brien C" first="C. F." last="O'Brien">C. F. O'Brien</name>
<affiliation><inist:fA14 i1="04"><s1>The Colorado Neurological Institute</s1>
<s2>Denver, Colorado</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Lewitt, P A" sort="Lewitt, P A" uniqKey="Lewitt P" first="P. A." last="Lewitt">P. A. Lewitt</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Neurology, Wayne State University School of Medicine</s1>
<s2>Detroit, Michigan</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Koller, W C" sort="Koller, W C" uniqKey="Koller W" first="W. C." last="Koller">W. C. Koller</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Neurology, University of Kansas Medical Center</s1>
<s2>Kansas City, Kansas</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1998">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chemotherapy</term>
<term>Clozapine</term>
<term>Human</term>
<term>Mental disorder</term>
<term>Multicenter study</term>
<term>Neuroleptic</term>
<term>Parkinson disease</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Trouble psychiatrique</term>
<term>Clozapine</term>
<term>Neuroleptique</term>
<term>Chimiothérapie</term>
<term>Traitement</term>
<term>Homme</term>
<term>Etude multicentrique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>13</s2>
</fA05>
<fA06><s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Clozapine use in Parkinson's disease : A retrospective analysis of a large multicentered clinical experience</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>TROSCH (R. M.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>FRIEDMAN (J. H.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>LANNON (M. C.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>PAHWA (R.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>SMITH (D.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>SEEBERGER (L. C.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>O'BRIEN (C. F.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>LEWITT (P. A.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>KOLLER (W. C.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology, Wayne State University School of Medicine</s1>
<s2>Detroit, Michigan</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Division of Neurology, Roger Williams Medical Center</s1>
<s2>Providence, Rhode Island</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurology, University of Kansas Medical Center</s1>
<s2>Kansas City, Kansas</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>The Colorado Neurological Institute</s1>
<s2>Denver, Colorado</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA20><s1>377-382</s1>
</fA20>
<fA21><s1>1998</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000075575650010</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1998 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>37 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>98-0262009</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02B03</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Trouble psychiatrique</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Mental disorder</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Trastorno psiquiátrico</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Clozapine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Clozapine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Clozapina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Neuroleptique</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Neuroleptic</s0>
<s5>08</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Neuroléptico</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>16</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Traitement</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Treatment</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="GER"><s0>Aufbereiten</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>17</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Etude multicentrique</s0>
<s5>23</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Multicenter study</s0>
<s5>23</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Estudio multicéntrico</s0>
<s5>23</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fN21><s1>173</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 98-0262009 INIST</NO>
<ET>Clozapine use in Parkinson's disease : A retrospective analysis of a large multicentered clinical experience</ET>
<AU>TROSCH (R. M.); FRIEDMAN (J. H.); LANNON (M. C.); PAHWA (R.); SMITH (D.); SEEBERGER (L. C.); O'BRIEN (C. F.); LEWITT (P. A.); KOLLER (W. C.)</AU>
<AF>Department of Neurology, Wayne State University School of Medicine/Detroit, Michigan/Etats-Unis (1 aut., 8 aut.); Division of Neurology, Roger Williams Medical Center/Providence, Rhode Island/Etats-Unis (2 aut., 3 aut.); Department of Neurology, University of Kansas Medical Center/Kansas City, Kansas/Etats-Unis (4 aut., 5 aut., 9 aut.); The Colorado Neurological Institute/Denver, Colorado/Etats-Unis (6 aut., 7 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1998; Vol. 13; No. 3; Pp. 377-382; Bibl. 37 ref.</SO>
<LA>Anglais</LA>
<CC>002B02B03</CC>
<FD>Parkinson maladie; Trouble psychiatrique; Clozapine; Neuroleptique; Chimiothérapie; Traitement; Homme; Etude multicentrique</FD>
<FG>Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative</FG>
<ED>Parkinson disease; Mental disorder; Clozapine; Neuroleptic; Chemotherapy; Treatment; Human; Multicenter study</ED>
<EG>Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease</EG>
<GD>Aufbereiten</GD>
<SD>Parkinson enfermedad; Trastorno psiquiátrico; Clozapina; Neuroléptico; Quimioterapia; Tratamiento; Hombre; Estudio multicéntrico</SD>
<LO>INIST-20953.354000075575650010</LO>
<ID>98-0262009</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003042 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 003042 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:98-0262009 |texte= Clozapine use in Parkinson's disease : A retrospective analysis of a large multicentered clinical experience }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |